← EPO Patent Bulletin

MODULATION OF ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY

Publication EP4326333A1 Kind: A1 Mar 18, 2026

Applicants

Seagen Inc.

Inventors

MOQUIST, Philip, LEVENGOOD, Matthew R., LEISKE, Christopher I., BINDMAN, Noah A.

IPC Classifications

A61K 47/60 20170101AFI20221028BHEP A61K 47/65 20170101ALI20221028BHEP C07K 16/28 20060101ALI20221028BHEP C07K 16/32 20060101ALI20221028BHEP A61P 35/00 20060101ALI20221028BHEP A61P 43/00 20060101ALI20221028BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR